Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-7,795
Closed -$260K 1241
2022
Q3
$260K Buy
7,795
+7
+0.1% +$291 0.01% 1033
2022
Q2
$337K Buy
7,788
+503
+7% +$23.1K 0.01% 983
2022
Q1
$349K Sell
7,285
-114
-2% -$5.65K 0.01% 997
2021
Q4
$375K Sell
7,399
-62
-0.8% -$2.76K 0.01% 999
2021
Q3
$302K Sell
7,461
-420
-5% -$21.3K 0.01% 1037
2021
Q2
$446K Buy
7,881
+2,484
+46% +$141K 0.01% 970
2021
Q1
$285K Buy
5,397
+18
+0.3% +$981 0.01% 973
2020
Q4
$294K Sell
5,379
-26
-0.5% -$1.37K 0.01% 953
2020
Q3
$271K Buy
+5,405
New +$256K 0.01% 895

Other funds holding NUS

Xponance's NUS Position: Q4 2022 in Review

Xponance sold out of Nu Skin (NUS) in Q4 2022, closing a stake of 7,795 shares — an estimated $260K sold.

Xponance first reported a position in NUS in Q3 2020 and held it in 9 quarters. The position peaked at $446K in Q2 2021. 218 funds tracked by Wall St. Rank hold NUS as of Q4 2022.

  • Xponance reported no remaining Nu Skin position as of Q4 2022 after selling out during the quarter.
  • Xponance sold 7,795 Nu Skin shares in Q4 2022, an estimated $260K.
  • Xponance first reported a position in Nu Skin in Q3 2020 and held it in 9 quarters.
  • Xponance's Nu Skin position peaked at $446K in Q2 2021.
  • 218 funds tracked by Wall St. Rank held Nu Skin as of Q4 2022.

Based on Xponance's 13F filing for Q4 2022, filed 24 Jan 2023.